Status:
COMPLETED
Combined Corneal Wavefront-guided TPRK and ACXL Following ICRS Implantation in Management of Moderate Keratoconus
Lead Sponsor:
Shaaban Elwan
Conditions:
Keratoconus
Eligibility:
All Genders
20-48 years
Phase:
NA
Brief Summary
Background: Keratoconus leads to gradual progressive loss of vision in young and adult patients. For visual rehabilitation and to hinder keratoconus progressionthe investigators designed this study to...
Detailed Description
Patients and Methods: This study conducted upon 36 eyes of 36 patients with moderate keratoconus who undergoing combined corneal wavefront-guided TPRK and accelerated corneal CXL at least 3 months af...
Eligibility Criteria
Inclusion
- Adult patient with age \> 20 years old and intolerant to contact lense use
- patients had moderate keratoconus (45-54 D in both meridians) without corneal scarring
- Central pachymetry ≥ 400 μm and if progression had been noted over the previous 6 months.
Exclusion
- Patients with central or paracentral corneal scarring
- Central pachymetry \<400 μm, systemic autoimmune disease
- History of herpetic keratitis, pregnancy, lactation, or severe dry eye syndrome.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04383301
Start Date
October 1 2018
End Date
April 30 2020
Last Update
May 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Security forces hospital
Riyadh, Central, Saudi Arabia, 11481-3643